Metraipolis › archive › dc_c9de222bc1fe
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders — Europe PMC PMID:41594662
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41594662
- DOI
- 10.3390/biom16010123
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:30:52.081Z
- SHA-256 of the archived text
8b4f455048423b90447fc86e22d57d93b27ad4d55505bb6319c848d24c35b166- Stable URL of this page
https://metraipolis.com/documento/dc_c9de222bc1fe
How to cite
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders — Europe PMC PMID:41594662 — Europe PMC (en), https://europepmc.org/article/MED/41594662 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c9de222bc1fe (Metraipolis archive dc_c9de222bc1fe, sha256 8b4f455048423b90447fc86e22d57d93b27ad4d55505bb6319c848d24c35b166)
BibTeX
@misc{dcc9de222bc1fe,
title = {BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders — Europe PMC PMID:41594662},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41594662},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c9de222bc1fe; sha256 8b4f455048423b90447fc86e22d57d93b27ad4d55505bb6319c848d24c35b166},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41594662. Agents can read the archived copy with the MCP tool read_document.